Status:
COMPLETED
Lay Health Worker Expanded Intervention in Community Oncology Practices
Lead Sponsor:
Stanford University
Conditions:
End of Life
Cancer
Eligibility:
All Genders
75-100 years
Phase:
NA
Brief Summary
Undertreated patient symptoms and resulting acute care use require approaches that improve symptom-burden. Previously a lay health worker (LHW)-led symptom screening intervention was developed for pat...
Detailed Description
All patients with newly diagnosed cancer, over the age of 75 will be randomized into the CareMore Pilot 2 Program with 200 randomized to the intervention grou and 200 randomized to the control group.
Eligibility Criteria
Inclusion
- Newly diagnosed or relapsed cancer diagnosis.
- 75 years or older
- Diagnosis of relapse or progressive disease (any cancer diagnosis) as identified by imaging or biopsy and confirmed by physician.
- Must have capacity to verbally consent
Exclusion
- Inability to consent to the study due to lack of capacity as documented by the referring physician.
Key Trial Info
Start Date :
October 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 17 2024
Estimated Enrollment :
416 Patients enrolled
Trial Details
Trial ID
NCT04463992
Start Date
October 5 2020
End Date
October 17 2024
Last Update
April 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Oncology Institute of Hope and Innovation
Tucson, Arizona, United States, 85710
2
The Oncology Institute of Hope and Innovation
Henderson, Nevada, United States, 89052